07.01.03
Novagen Limited, Madison, WI, has been granted a U.S. patent for the use of its isoflavone technology in the treatment of the symptoms of menopause and pre-menstrual syndrome (PMS). The patent applies to the isoflavones genistein, daidzein, formononetin and biochanin.